Heterogeneity index score (HIS). New computerized method for classification of human bladder carcinomas using flow...

Area of Science:

• Oncology
• Biotechnology
• Computational Biology

Background:

• Nuclear DNA content is linked to cancer aggressiveness.
• Current flow cytometry (FCM) methods have limitations in assessing tumor aneuploidy and proliferation.
• Accurate quantification of tumor cell characteristics is crucial for diagnosis and treatment.

Purpose of the Study:

• To develop and validate a new computerized methodology for analyzing nuclear DNA content in cancer cells.
• To establish a heterogeneity index (HI) correlated with relative mean DNA content from FCM.
• To objectively differentiate tumor malignancy grades using FCM data.

Main Methods:

• Developed a computerized method to calculate a heterogeneity index (HI) from FCM data.
• Analyzed 76 tissue samples (22 benign, 54 malignant bladder tumors) using mechanical mincing and propidium iodide staining.
• Utilized an Ortho system 50-H multiparameter flow cytometer and computer for DNA content and cell number determination.

Main Results:

• Mean HI for benign tissues was 9.805.
• Mean HI for Grade I-II tumors was 23.576, showing a statistically significant difference from benign tissue (P=0.0196).
• Grade III tumors exhibited a markedly increased mean HI of 160.965; carcinoma in situ showed a mean HI of 45.4.

Conclusions:

• The new computerized methodology provides an objective description of FCM characteristics.
• The heterogeneity index (HI) effectively quantifies tumor malignancy and may distinguish between different grades of bladder cancer.
• This approach enhances the diagnostic potential of flow cytometry in cancer research.